Efficacy, Safety and Immunogenecitystudy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Follicular Lymphoma Preliminary report (HERILY)

To compare the antitumor efficacy, safety, and pharmacodynamics (PD) characteristics of Hetero-Rituximab (test) with Reference Medicinal Product (Rituximab, Roche) in Non-Hodgkin's Lymphoma (NHL). Total 40 Follicular Lymphoma (FL) patients were randomized to receive intravenous infusion of eith...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the Association of Physicians of India 2017-10, Vol.65 (12), p.58-62
Hauptverfasser:	Advani, Suresh, Sinha, Shubhadeep, Thakur, Pankaj, Naidu, Neetu, Chary, Sreenivas, Biswas, Ghanshyam, Bandi, Vamsi Krishna
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!